/Quest%20Diagnostics%2C%20Inc_%20sign-%20by%20Sundry%20Photogreaphy%20via%20Shutterstock.jpg)
Valued at a market cap of $20.1 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing, information, and services in the United States and internationally. The company serves a wide range of healthcare providers through its two main business groups: Diagnostic Information Services and Diagnostic Solutions. The Secaucus, New Jersey-based company is slated to announce its fiscal Q2 2025 earnings results before the market opens on Tuesday, Jul. 22.
Ahead of the event, analysts are expecting DGX to report an adjusted EPS of $2.56, up 8.9% from $2.35 in the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in the past four quarterly reports. In Q1 2025, Quest Diagnostics exceeded the consensus adjusted EPS estimate by 2.8%.
